21 employees
TargImmune Therapeutics is focused on drug development using novel targeted onco-immunotherapies.
2016
$82K
from 1 investors over 1 rounds
TargImmune Therapeutics AG raised $82K on January 1, 2019
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)